Search

everythinglearnresearchcommunity

for

Search:↓

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Estrogen affects hair growth and skin cell multiplication.

Hormones during puberty increase certain receptors in the brain, and this change is influenced by estrogen levels.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

New treatments for male hypogonadism are effective and should be personalized.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

A male with aromatase deficiency improved bone health with estradiol treatment.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Hirsutism causes significant psychological distress in women.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.